Japanese pharmas stingy in donating money as social contributions

Although Japanese pharmaceutical companies branching in Korea are growing up with product quality and marketing power, they are criticized to neglect social contributions of corporate profit, which are a fundamental duty.

Yakup Shinmoon analyzed 9 Japanese pharmaceutical companies’ 2016 audit reports. The analysis showed they only donated the total KRW 3.675 billion last year.

This means they...